Lihong Du

662 total citations
27 papers, 483 citations indexed

About

Lihong Du is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Lihong Du has authored 27 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Biomedical Engineering and 4 papers in Oncology. Recurrent topics in Lihong Du's work include Microbial Metabolic Engineering and Bioproduction (6 papers), Biofuel production and bioconversion (5 papers) and Analytical Chemistry and Chromatography (4 papers). Lihong Du is often cited by papers focused on Microbial Metabolic Engineering and Bioproduction (6 papers), Biofuel production and bioconversion (5 papers) and Analytical Chemistry and Chromatography (4 papers). Lihong Du collaborates with scholars based in United States, China and Switzerland. Lihong Du's co-authors include Donald G. Musson, Robert L. White, Ning Chen, Yi Cui, Xixian Xie, John A. Wagner, Marian Iwamoto, Qingyang Xu, Nancy Agrawal and Keith Gottesdiener and has published in prestigious journals such as Clinical Cancer Research, Journal of Hepatology and Annals of the Rheumatic Diseases.

In The Last Decade

Lihong Du

27 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lihong Du United States 12 260 72 71 55 51 27 483
Saeed Rezaee Iran 12 81 0.3× 46 0.6× 31 0.4× 25 0.5× 41 0.8× 43 433
Ravinder Earla United States 13 162 0.6× 50 0.7× 45 0.6× 19 0.3× 25 0.5× 18 516
Fatema Bhinderwala United States 14 382 1.5× 37 0.5× 49 0.7× 66 1.2× 37 0.7× 23 596
Dwaipayan Mukherjee United States 11 339 1.3× 126 1.8× 55 0.8× 16 0.3× 23 0.5× 30 708
Rahul Vats India 10 124 0.5× 34 0.5× 77 1.1× 17 0.3× 32 0.6× 20 468
André Huss Eriksson Denmark 12 99 0.4× 96 1.3× 24 0.3× 45 0.8× 31 0.6× 17 487
Lisa Gruber Germany 17 319 1.2× 68 0.9× 50 0.7× 16 0.3× 13 0.3× 21 677
Henri Humbert France 15 77 0.3× 55 0.8× 71 1.0× 58 1.1× 29 0.6× 33 590
Franklin W. Okumu United States 9 317 1.2× 118 1.6× 71 1.0× 25 0.5× 27 0.5× 12 644
Karen F. Wilkinson United States 11 216 0.8× 117 1.6× 38 0.5× 26 0.5× 23 0.5× 16 585

Countries citing papers authored by Lihong Du

Since Specialization
Citations

This map shows the geographic impact of Lihong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihong Du more than expected).

Fields of papers citing papers by Lihong Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihong Du. The network helps show where Lihong Du may publish in the future.

Co-authorship network of co-authors of Lihong Du

This figure shows the co-authorship network connecting the top 25 collaborators of Lihong Du. A scholar is included among the top collaborators of Lihong Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihong Du. Lihong Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Lihong, Yuexin Chen, Zuoguan Chen, et al.. (2024). Association between premature vascular smooth muscle cells senescence and vascular inflammation in Takayasu's arteritis. Annals of the Rheumatic Diseases. 83(11). 1522–1535. 7 indexed citations
2.
Li, Yongchao, et al.. (2024). High expression of CASP1 induces atherosclerosis. Medicine. 103(16). e37616–e37616. 1 indexed citations
3.
Du, Lihong, Qian Ma, Yuhao Yuan, et al.. (2022). Conjunctive Analyses of Bulk Segregant Analysis Sequencing and Bulk Segregant RNA Sequencing to Identify Candidate Genes Controlling Spikelet Sterility of Foxtail Millet. Frontiers in Plant Science. 13. 842336–842336. 9 indexed citations
4.
Brookfield, Kathleen, Hadiza Galadanci, Lihong Du, et al.. (2021). Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia. AJOG Global Reports. 1(4). 100018–100018. 3 indexed citations
5.
Du, Lihong, Zhen Zhang, Qingyang Xu, & Ning Chen. (2019). Central metabolic pathway modification to improve L-tryptophan production in Escherichia coli. Bioengineered. 10(1). 59–70. 21 indexed citations
6.
Caro, Luzelena, Larissa Wenning, Hwa-ping Feng, et al.. (2019). Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment. European Journal of Clinical Pharmacology. 75(5). 665–675. 10 indexed citations
7.
Du, Lihong, Larissa Wenning, Brendan Carvalho, et al.. (2019). Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure‐Response Modeling and Simulation Study. The Journal of Clinical Pharmacology. 59(11). 1519–1526. 6 indexed citations
8.
Chen, Qixin, Yi Cui, Lihong Du, et al.. (2018). Comparative Genomic and Genetic Functional Analysis of Industrial L-Leucine– and L-Valine–Producing Corynebacterium glutamicum Strains. Journal of Microbiology and Biotechnology. 28(11). 1916–1927. 19 indexed citations
9.
Cui, Yi, et al.. (2018). Identification and application of a growth-regulated promoter for improving l-valine production in Corynebacterium glutamicum. Microbial Cell Factories. 17(1). 185–185. 35 indexed citations
10.
Rizk, Matthew L., Lihong Du, Larissa Wenning, et al.. (2015). Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV‐infected children 4 weeks to 18 years of age. The Journal of Clinical Pharmacology. 55(7). 748–756. 13 indexed citations
11.
Du, Lihong, et al.. (2011). A Study on Enhancement of Filtration Process with Filter Aids Diatomaceous Earth and Wood Pulp Cellulose. Chinese Journal of Chemical Engineering. 19(5). 792–798. 20 indexed citations
12.
Du, Lihong, et al.. (2009). A flexible and high throughput liquid chromatography–tandem mass spectrometric assay for the quantitation of telcagepant in human plasma. Journal of Chromatography B. 877(14-15). 1465–1471. 1 indexed citations
13.
Du, Lihong & Robert L. White. (2008). Reducing glycerophosphocholine lipid matrix interference effects in biological fluid assays by using high‐turbulence liquid chromatography. Rapid Communications in Mass Spectrometry. 22(21). 3362–3370. 24 indexed citations
14.
Du, Lihong & Robert L. White. (2008). Improved partition equilibrium model for predicting analyte response in electrospray ionization mass spectrometry. Journal of Mass Spectrometry. 44(2). 222–229. 11 indexed citations
15.
Du, Lihong, et al.. (2006). Stability studies of vorinostat and its two metabolites in human plasma, serum and urine. Journal of Pharmaceutical and Biomedical Analysis. 42(5). 556–564. 40 indexed citations
16.
Rubin, Eric H., Nancy Agrawal, Evan Friedman, et al.. (2006). A Study to Determine the Effects of Food and Multiple Dosing on the Pharmacokinetics of Vorinostat Given Orally to Patients with Advanced Cancer. Clinical Cancer Research. 12(23). 7039–7045. 94 indexed citations
17.
Xu, Yang, Lihong Du, Mark J. Rose, et al.. (2005). Concerns in the development of an assay for determination of a highly conjugated adsorption-prone compound in human urine. Journal of Chromatography B. 818(2). 241–248. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026